I reported last year on the three-part article series published in EPI Information by Tamaris Bucher, Principal Patent Attorney at Novartis, on the EPO’s approach to assessing inventive step for…
As most IP practitioners will be aware, on 25 February 2025 the Court of Justice of the European Union handed down its ruling in BSH v Electrolux (C-339/22). In summary, the CJEU concluded that it is…
Moderna secured a double victory in the Patents Court last week (2 July 2024) in proceedings against Pfizer and BioNTech. In the first decision, Meade J found its modified mRNA patent to be valid…
On 24 April 2024, the UPC’s Central Division in Paris granted Nicoventures Trading Limited access to written pleadings and evidence under RoP 262.1(b) in a patent revocation case brought by NJOY…
